(E)-3-(2-Methoxypyridin-3-yl)acrylic acid, 98%, 250mg

TERT-BUTYL 4-((4-(HYDROXYMETHYL)PIPERIDIN-1-YL)METHYL)BENZOATE, 90.0%, 1g

Trihexyl(tetradecyl)phosphonium Dicyanamide>93.0%(N)5g

tert-Butyl (2-((4-chlorobenzyl)amino)ethyl)carbamate, 95.0%, 1g

Hydrazine Dihydrochloride>98.0%(T)25g

Ethyl 2,2-difluoroheptanoate, 95.0%, 1g

Microliter syringe GASTIGHT® series 1700 Point type 2, 500 µl, 1750 RN, 1 piece

N-Boc-4-Carboxymethoxypiperidine, 95.0%, 5g

(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid, 50mg

N,N-Dimethyl-2,2-dimethylpropanamide, 95.0%, 1g

Indium(III) chloride, min. 99.9%, pa, 50 g, plastic packaging.

Ethyl 5-methyl[1,2,4]oxadiazole-3-carboxylate, 95.0%, 1g